Jump to:
Think Fabrazyme first, think dedicated support
Financial Assistance Programs
Designed to help your eligible patientsa living with a rare disease.
Sanofi is committed to helping your patients navigate each state of their treatment journey. We offer a range of support services from copay assistance to personalized patient support to address your patients’ unique needs.
Copay Assistance Programa
The CareConnect Copay Assistance Program helps eligible patients in the United States who are prescribed Fabrazyme pay for their qualifying out-of-pocket drug costs and certain infusion-related (mixing and administration of the drug, as well as infusion supplies such as saline, IV tubing, etc.) expenses, including copays, coinsurance, and deductibles.
Patients or their caregivers interested in applying for the CareConnect Copay Program will need to complete the application. The application can be downloaded below. Patients or their caregivers can also complete this application online. They can call the team at 1-800-745-4447, option 3, to learn how.
Patient assistance program
If your patient does not have insurance, or their insurance has denied coverage for Fabrazyme, they may be eligible to receive Fabrazyme through the CareConnect Patient Assistance Program (PAP). To see if your patient qualifies, you will need to initiate a CareConnect PAP application. This can be done on paper or online, call the team at 1-800-745-4447, option 3, to learn how.
aPatients whose medication or infusion-related costs are covered by a state or federal health care program, including but not limited to Medicare, Medicare Part D, Medigap, Medicaid, Veterans Affairs (VA), Department of Defense (DoD), or TRICARE, are not eligible for the Co-Pay Program. Patients must live in the US or a US territory. Patients must be eligible under applicable state law(s). Other terms and conditions of the Program apply. Co-Pay Program does not cover or provide support for MD office visits/evaluations, nursing services/observation periods, blood work, x-rays or other testing, pre-medications/other medications, transportation or other related services associated with treatment. In accordance with state law, infusion-related costs are not covered for commercially insured patients residing in MA or RI. Sanofi reserves the right to modify or discontinue the programs at any time without notice. Savings may vary depending on patients’ out-of-pocket costs. All program details provided upon registration.
Billing and reimbursement for Fabrazyme
Treatment with Fabrazyme is a covered benefit under most major insurance plans, as well as Medicare and Medicaid programs. Sanofi is committed to working with providers, as well as public and private payers, to help ensure access to treatment for patients who would medically benefit from Fabrazyme.
%20(1).svg)
Blanca, a real Fabrazyme patient
“Throughout my journey, I have also received great support from the team at Sanofi. They have not only been a tremendous resource, but they have provided me the opportunity to share my story with others.”
